The path forward For 5-amino-1mq to move from research compound to established therapy, human clinical trials are needed
2Case Western Reserve University School of Medicine, Cleveland, OH Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly prescribed for type 2 diabetes and obesity
Similar results were reported with quercetin (181, 182)
(3) This process enhances circulation to injured or damaged tissues , delivering oxygen and nutrients that accelerate healing
Although extensive research has determined that GLP-1s are safe, this medication does have side effects, including nausea, vomiting, fatigue, dizziness, constipation, and diarrhea